ESC Premium Access

Hepatocyte growth factor has prognostic utility in light chain and transthyretin cardiac amyloidosis

Congress Presentation

About the speaker

Doctor Jennifer Miao

Vanderbilt University Medical Center, Nashville (United States of America)
0 follower

8 more presentations in this session

Role of 18FDG(fluorodeoxyglucose)-PET (positron emission tomography) for differential diagnosis of pericardial disease

Speaker: Doctor C. Hyeon (Seoul, KR)

Thumbnail

Interim analysis of data from a long-term, extension trial of tafamidis meglumine in patients with transthyretin amyloid cardiomyopathy

Speaker: Doctor S. Gottlieb (Baltimore, US)

Thumbnail

Tafamidis versus liver transplantation as first-line therapy for hereditary transthyretin amyloidosis

Speaker: Doctor V. Algalarrondo (Paris, FR)

Thumbnail

Myocardial perfusion mapping in cardiac amyloidosis- exploring the spectrum from infiltration to ischaemia

Speaker: Doctor T. Kotecha (London, GB)

Thumbnail

The increased serum level of troponin T after immunosuppression therapy reflects sustained myocardial FDG accumulation in cardiac sarcoidosis

Speaker: Doctor R. Morimoto (Nagoya, JP)

Thumbnail

Access the full session

Hot topics in myocardial and pericardial diseases

Speakers: Doctor J. Miao, Doctor C. Hyeon, Doctor S. Gottlieb, Doctor V. Algalarrondo, Doctor T. Kotecha...
Thumbnail

About the event

Image

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb